chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nose got swollen; Bridge of nose was very red; Glands on the bottom of his jaw got swollen and sensitive; Whole skin was very tender and warm; Whole skin was very tender and warm; This is a spontaneous report from a contactable consumer. This male contactable consumer (patient) reported for himself that: A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number were not reported, NDC number and Expiry Date: Not Provided), via unspecified route administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient had previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number were not reported, NDC number and Expiry Date: Not Provided), via unspecified route administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. On an unspecified date after the second dose of vaccination, the patient experienced nose got swollen, bridge of nose was very red, glands on the bottom of his jaw got swollen and sensitive and whole skin was very tender and warm. It was reported that, patient reported he was administered the second dose of Pfizer COVID-19 Vaccine injection on Friday. Starting last night his nose got swollen; the bridge of his nose was very red; and the whole skin was very tender and warm; the glands on the bottom of his jaw got swollen and sensitive. Patient called to ask if he should worry about these events or if he should take some medication for them. Patient: Sex: Patient referred to as male during this report, but sex not verified with caller who was unwilling to complete report. The outcome of events was reported as unknown.  No follow up attempts are possible. Information about lot/batch number cannot be obtained.
After dose #1, nausea, headache both started approximately 5 1/2 hours after injection.  After second dose, flu like symptoms ? nausea, vomiting, abdominal pain, &  bodyaches. Missed two days from work. Symptoms started approximately six hours after injection
pt recv vax & had localized rxn secondary to receiving vax in rt arm;pt was given med w/good relief;
Effects reported/all symptoms have stopped; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ADVERSE EVENT (Effects reported/all symptoms have stopped) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Effects reported/all symptoms have stopped). At the time of the report, ADVERSE EVENT (Effects reported/all symptoms have stopped) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by reporter. No treatment medication was reported by reporter.   This case was linked to MOD-2021-372607 (Parent-Child Link).   See case MOD-2021-372607 for details regarding the child case.
shortness of breath 3 days after 2nd dose injected. admitted on 2/19 shortness of breath admitted on 2/26 shortness of breath admitted on  3/2 cardiac arrest, neck mass, seizure like activity, acute respiratory failure died on 3/06/2021
pt recv vax 23OCT95 & devel pain, weakness, confusion & fatigue;pt to ER 10FEB96 w/chest pain;was evaluated & released;pt was found to have positive Epstein Barr titer;pt believes all sx were a result of the inj;
Covid arm, large red patch 2?x 2?, swelling, hot, sore arm, fever, chills, sore body, headache
Pt presented w/swelling of left arm (she stated it looked like bubbling of the skin w/fluid) over entire area of injection. She received Prednisone 20 mg and ATARAX 50 mg.
Noticed body itching and hives/swelling on face day following injection. Hives and itching increased for 3 days following the shot. I am not allergic to eggs and have not had an adverse reaction to previous flu vaccines. At 3 day point, started following regimen of washing all over with benzoyl peroxide/sulfur cleanser, and layering benadryl gel, coal tar gel, calamine & zinc oxide, sulfur ointment on face to relieve the hives/swelling. This helped to alleviate the hives and swelling.
Full body itchiness; Red face; Hives on left arm; Tightness in throat; coughing; This is a spontaneous report from a contactable consumer (patient).   A 43-year-old female patient (no pregnant) received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 21Jun2021 at 10:00 AM at 43-year-old as single dose for COVID-19 immunization. Medical history was reported as: known allergies included: Sulfa, seaonal allergy, milk, allergy shots, and penicillin shot. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. Concomitant medication included Clarithromycin (CLARITIN) within 2 weeks of vaccination. On 21Jun2021 at 11:15 AM, the patient experienced full body itchiness, red face, hives on left arm and tightness in throat and coughing. High dose of Benadryl and antihistamine were received as treatment. The outcome of events was recovered.  Information on the lot/batch number has been requested.
I woke up in the morning with large, itchy hives all over my torso. I treated it with Zyrtec which helped the itching but not the hives presence. The hives spread to my limbs the next day and then my hands/feet/face the next day. I then sought medical treatment. By day 3 the joints in my hands and feet hurt.
Pain at injections site, chills fever, intense back pain, swelling of back, headache
Almost immediately, tongue went numb / began tingling, throat felt tight  Same reaction had as first dose however took cetirizine about an hour before the vaccination, the reaction was much less than the first time.
Day 1 - muscle tenderness in injection arm Day 2 - 1" warm red spot at injection site, tender to touch, muscle tenderness more pronounced Day 3 - 3" warm red spot at injection site, tender to touch, muscle tenderness more pronounced Day 4 - 4.5" warm red spot at injection site, tender to touch, muscle tenderness less pronounced as is redness at injection site
minor skin eruption; This spontaneous case was reported by a consumer and describes the occurrence of RASH (minor skin eruption) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (minor skin eruption). At the time of the report, RASH (minor skin eruption) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient reported not on any medications.  Treatment information was not provided.  After the 1st and 2nd dose Moderna, the patient broke out with minor skin eruption. After the booster dose, the patient had a stinging sensation, itching and took about a 1-2 week before getting an eruption. He visited a medical doctor and a dermatologist, and was prescribed an antihistamine and a steroid pack The symptoms are starting to resolve after taking an antihistamine (either Zyrtec or Claritin).   This case was linked to MOD-2022-454183, MOD-2022-454200 (Patient Link).
Reaction noted to (L) upper arm - site of TDAP extending from shoulder midway to elbow - redness, heat, swelling; pt states is improved; will switch from TYLENOL to Ibuprofen and if not resolved this week will consult PCP.
Apparent vaccine failure. Pt presented 5/18/09 with typical herpes zoster skin lesions.
Site: Pain at Injection Site-Severe, Additional Details: Patient wife came in to say patient having trouble moving right hand. Not able to open and close fist a couple of days since vaccine admin.
He is lethargic and is vomiting.; He is lethargic and is vomiting.; This is a spontaneous report from a contactable consumer (patient's wife) from a Pfizer-sponsored program. A male patient of an unknown age received second dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, batch/lot number: unknown) via an unspecified route of administration on 12Feb2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medication was not reported. It was reported that caller's husband had his second COVID shot last 12Feb2021. He was lethargic and was vomiting. The outcome of the events was unknown.    Information about lot/batch number has been requested. Follow-up attempts are completed. No further information was expected.
Approx 1.5 hrs post vax pt began w/generalized shaking-to MD t101, BP 102/84, p104, alert, oriented; Peripheral cyanosis, poor capillary fill in nailbeds, skin warm; Given 02 & Epinephrine; To ER only semi-alert;
i got my flu shot and now test positive for the flu; Initial information received on 05-Dec-2022 regarding an unsolicited valid social media non-serious case from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who got INFLUENZA VACCINE shot and now test positive for the flu.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination (immunisation).  On an unknown date the patient got flu shot and now test positive for the flu (influenza) (unknown latency) following the administration of influenza vaccine.  Relevant laboratory test results included: Influenza virus test - On an unknown date: Positive   Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
Legs start to hurt and it radiates to lower stomach; Legs start to hurt and it radiates to lower stomach; Fever; Nausea; Headache; Chills; Cannot breathe; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Cannot breathe), PAIN IN EXTREMITY (Legs start to hurt and it radiates to lower stomach), ABDOMINAL PAIN LOWER (Legs start to hurt and it radiates to lower stomach), PYREXIA (Fever) and NAUSEA (Nausea) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced DYSPNOEA (Cannot breathe), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills). On 30-Apr-2021, the patient experienced PAIN IN EXTREMITY (Legs start to hurt and it radiates to lower stomach) and ABDOMINAL PAIN LOWER (Legs start to hurt and it radiates to lower stomach). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Cannot breathe), PAIN IN EXTREMITY (Legs start to hurt and it radiates to lower stomach), ABDOMINAL PAIN LOWER (Legs start to hurt and it radiates to lower stomach), PYREXIA (Fever), NAUSEA (Nausea), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported
& SWOLLEN; RED; WARM; ITCHY DIPHENHYDRAMINE OTC Benadryl PRN MG PRN, CEPHALEXIN 500 MG QID
8 days after vaccination she developed a sizable area of red, itchy skin near the injection site
Severe pain  at lower left rib cage.  Transit to all upper body. Still in progress.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 15-APR-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) lot # K025766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
TD given 4/20, 4/21 pt seen- area red, warm & swollen right deltoid approx size of egg without fluctuance plus tender. Prescription: Duricef 500 BID for 7 days. Use ice and rest arm. Take IBP. Call if not resolved.
Patient fainted about 5 to 10 minute after receiving dose of COVID-19 vaccine.  He was very rigid and not responsive to commands.  This went on for a few minutes, patient was placed on the ground where he gained consciousness and responsive to commands.  Upon coming to patient did say this had happened in the past but he was sorry he failed to mention it.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 57 year old female patient. No information was provided regarding concomitant medications, concurrent conditions or medical history. Approximately on 22-AUG-2017, when the pt was 55 years old, she was vaccinated by a pharmacist with zoster vaccine live (ZOSTAVAX) for long term prevention of shingles and zoster-related conditions. On an unknown date, the pt experienced herpes zoster resulting from zoster vaccine live (ZOSTAVAX) use and she received treatment from a healthcare provider at the facility. The outcome of herpes zoster was unknown. The reporter considered herpes zoster to be related to Zoster Vaccine Live(ZOSTAVAX).
I am only having soreness of arms.; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female (patient) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot/batch number: not reported) via an unspecified route of administration on 27Feb2021 (at the age of 69 years) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had her first shot and she was due to see her primary care doctor on 10Mar2021 where she would get a Cortisone shot in her knee. She was wondering if that would cause any reaction with the COVID-19 vaccine. The second shot of vaccine would be on 20Mar2021. On an unknown date, the patient was only having soreness of arms. The outcome of event was unknown.  No follow-up attempts are possible; Information about Lot/Batch number cannot be obtained.
On 11/16/2022, my husband had a cardiac event. A few weeks prior to that he was coughing a lot which progressed into wheezing. I thought he had pneumonia. That went on for a couple of weeks until he finally went to the emergency room with me. At the emergency room, they diagnosed that he had damaged heart muscles and had to be medevacked to larger facility for further care. There were no catheterization labs where we live, and he had to have two stints placed in two different arteries. He is still under treatment and having to take several more medications along with an aspirin regimin. His cognitive abilities have also declined since the event.
Pt fell from chair and hit head on the ground and vomited . EMS was called and Patient was taking to ER . Patient was awake and taking though disoriented initialy .
skin issue/skin issue around the eyes, mouth, palm all broken out/comes and goes; It burns/on the sides of the mouth and the lips they just burns; Dry skin; I'm having stuff i never had, had seraph but in the legs, the mouth and the eyes have never been; it's dry, on the sides of the mouth and the lips; Itchy; Redness/It's all over my neck. It just everywhere"; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOMFORT (skin issue/skin issue around the eyes, mouth, palm all broken out/comes and goes), SKIN BURNING SENSATION (It burns/on the sides of the mouth and the lips they just burns), DRY SKIN (Dry skin), FEELING ABNORMAL (I'm having stuff i never had, had seraph but in the legs, the mouth and the eyes have never been) and LIP DRY (it's dry, on the sides of the mouth and the lips) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013421A and 012A20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (COVID-19 positive and was hospitalized 8 days) in August 2020 and Lumpectomy.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SKIN DISCOMFORT (skin issue/skin issue around the eyes, mouth, palm all broken out/comes and goes), SKIN BURNING SENSATION (It burns/on the sides of the mouth and the lips they just burns), DRY SKIN (Dry skin), FEELING ABNORMAL (I'm having stuff i never had, had seraph but in the legs, the mouth and the eyes have never been), LIP DRY (it's dry, on the sides of the mouth and the lips), PRURITUS (Itchy) and ERYTHEMA (Redness/It's all over my neck. It just everywhere"). The patient was treated with PREDNISONE for Adverse event, at a dose of UNK, qid 7 days. At the time of the report, SKIN DISCOMFORT (skin issue/skin issue around the eyes, mouth, palm all broken out/comes and goes), SKIN BURNING SENSATION (It burns/on the sides of the mouth and the lips they just burns), DRY SKIN (Dry skin), FEELING ABNORMAL (I'm having stuff i never had, had seraph but in the legs, the mouth and the eyes have never been), LIP DRY (it's dry, on the sides of the mouth and the lips), PRURITUS (Itchy) and ERYTHEMA (Redness/It's all over my neck. It just everywhere") had resolved. Unknown      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter. Laboratory details: Biopsy done but results were not provided
Patient awoke with a high fever 103, was given TYLENOL and still had 103 temp afterward, Pt. felt achy and had no appetite.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 23-MAY-2013, the patient was vaccinated with a first dose of GARDASIL (lot number, expiration date, dose and route were not reported). On 16-JUL-2013, the patient was vaccinated with a second dose of GARDASIL (lot number 668260/1570Z, expiration date 06-APR-2013) (dose and route were not reported) for vaccination. Concomitant therapy was not reported. On 16-JUL-2013, a patient received an expired dose of GARDASIL. No adverse event reported. Additional information has been requested.
Patient received Vaccine Booster (Dose 3) which had hindsight was expired past 10 weeks in refrigerator temperatures.  (17 days Past date Expired 4/11/22) Called Patient 5/13/22 Disappointed, but did not experience side effects. May consider revaccination after speaking with provider
Started with body aches at 5:35PM on 4/1, and slight fever of 99.4F.  Both increased into the evening and lasted all night.  Highest recorded temp was 100.8F at about 2:30AM on 4/2.  By 6AM on 4/2. the fever dropped to 99.4F.
Patient presented to emergency department  with shortness of breath and increased oxygen demand. She had a positive home COVID-19 test that was positive on 11/7/2021. Patient was admitted to hospital for further management and treated with dexamethasone, remdesivir and continued on supplemental oxygen. Patient was discharged home on 11/14/2021.
Received only the liquid component; Received only the liquid component; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 13-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA758A, expiry date 30th November 2023) for prophylaxis.   On 12th December 2022, the patient received the 1st dose of Menveo. On 12th December 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 14-DEC-2022 Reporter's comment: The nurse reported that the patient received only the liquid conjugated component of Menveo (without the powder). The vaccine administration facility was the same as primary reporter. The reporter consented to follow up by fax. Additional Supportive Information: The patient received only the liquid conjugated component of Menveo (without the powder), which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Pt. developed fever and inconsolable x 3 days. Pt. seen on day 5. She still has symptoms but doing well. No fever. Consolable.
swelling in left breast area; soreness left breast area; swelling under her left arm pit; soreness under left arm pit; Left arm soreness; headache / headache worse; This spontaneous case was reported by a consumer and describes the occurrence of BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit) and MYALGIA (Left arm soreness) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, NORGESTREL (CRYSELLE) for an unknown indication.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit), MYALGIA (Left arm soreness) and HEADACHE (headache / headache worse). At the time of the report, BREAST SWELLING (swelling in left breast area), BREAST PAIN (soreness left breast area), SWELLING (swelling under her left arm pit), AXILLARY PAIN (soreness under left arm pit), MYALGIA (Left arm soreness) and HEADACHE (headache / headache worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was not provided.
pt recv vax 28OCT97 & exp malaise, sore throat & pain @ the inj site;sx persisted 1mo post vax;
Injected arm swollen shoulder to elbow; Severe pain in muscle injected; immobility of injected arm; slept 40 hrs straight after injection, after that, extreme fatigue, loss of appetite, chills. Three days after shot daily bouts of diarrhea which continues.
A constant high-pitched hissing in both ears & numb/tingling toes and feet.
Pt called stating she had a rash all over her body.  Was seen in the ED at  Hospital but they just thought it was a rash from the vaccine.  Then 3 weeks later the ED doctor called stating the patient was having cardiac episodes from the COVID-19 vaccine
PATIENT FAINTED AND RECOVERED CONSCIOUSNESS WITHIN ONE MINUTE. OCURRED WITHIN 5 MINUTES OF BEING VACCINATED